Literature DB >> 26511735

High Prevalence of Mycoplasma faucium DNA in the Human Oropharynx.

Sophie Edouard1, Gaëlle Denis Courtois2, Philippe Gautret3, Jean-Luc Jouve4, Philippe Minodier5, Guilhem Noël5, Antoine Roch6, Philippe Brouqui3, Andreas Stein7, Michel Drancourt1, Pierre-Edouard Fournier1, Didier Raoult8.   

Abstract

Mycoplasma faucium has recently been associated with brain abscesses and seems to originate from the mouth. We evaluated its prevalence by quantitative real-time PCR (qPCR) in the oropharynxes of 644 subjects and found that 25% harbored M. faucium, probably constituting the gateway for entrance of the bacteria into cerebral abscesses.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26511735      PMCID： PMC4702739          DOI： 10.1128/JCM.02068-15

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   11.677


  10 in total

1.  Metagenomic analysis of brain abscesses identifies specific bacterial associations.

Authors:  Mouhamad Al Masalma; Michel Lonjon; Hervé Richet; Henry Dufour; Pierre-Hugues Roche; Michel Drancourt; Didier Raoult; Pierre-Edouard Fournier
Journal:  Clin Infect Dis       Date:  2011-12-05       Impact factor: 9.079

Review 2.  Brain abscess.

Authors:  Matthijs C Brouwer; Allan R Tunkel; Guy M McKhann; Diederik van de Beek
Journal:  N Engl J Med       Date:  2014-07-31       Impact factor: 91.245

3.  Complementarity between targeted real-time specific PCR and conventional broad-range 16S rDNA PCR in the syndrome-driven diagnosis of infectious diseases.

Authors:  A-S Morel; G Dubourg; E Prudent; S Edouard; F Gouriet; J-P Casalta; F Fenollar; P E Fournier; M Drancourt; D Raoult
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-10-28       Impact factor: 3.267

4.  Mycoplasma salivarium isolated from brain abscesses.

Authors:  I Ørsted; J B Gertsen; H C Schønheyder; J S Jensen; H Nielsen
Journal:  Clin Microbiol Infect       Date:  2011-03-01       Impact factor: 8.067

Review 5.  Mycoplasmas and ureaplasmas as neonatal pathogens.

Authors:  Ken B Waites; Brenda Katz; Robert L Schelonka
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

Review 6.  Antibiotic susceptibilities of mycoplasmas and treatment of mycoplasmal infections.

Authors:  D Taylor-Robinson; C Bébéar
Journal:  J Antimicrob Chemother       Date:  1997-11       Impact factor: 5.790

7.  Use of rpoB sequences for phylogenetic study of Mycoplasma species.

Authors:  Kil-Soo Kim; Kwan Soo Ko; Myoung-Woong Chang; Tae Wook Hahn; Seong Karp Hong; Yoon-Hoh Kook
Journal:  FEMS Microbiol Lett       Date:  2003-09-26       Impact factor: 2.742

8.  Characterization of a newly identified mycoplasma (Mycoplasma orale type 3) from the human oropharynx.

Authors:  H Fox; R H Purcell; R M Chanock
Journal:  J Bacteriol       Date:  1969-04       Impact factor: 3.490

9.  The expansion of the microbiological spectrum of brain abscesses with use of multiple 16S ribosomal DNA sequencing.

Authors:  Mouhamad Al Masalma; Fabrice Armougom; W Michael Scheld; Henri Dufour; Pierre-Hugues Roche; Michel Drancourt; Didier Raoult
Journal:  Clin Infect Dis       Date:  2009-05-01       Impact factor: 9.079

10.  Lack of MERS coronavirus but prevalence of influenza virus in French pilgrims after 2013 Hajj.

Authors:  Philippe Gautret; Rémi Charrel; Samir Benkouiten; Khadidja Belhouchat; Antoine Nougairede; Tassadit Drali; Nicolas Salez; Ziad A Memish; Malak Al Masri; Jean-Christophe Lagier; Matthieu Million; Didier Raoult; Philippe Brouqui; Philippe Parola
Journal:  Emerg Infect Dis       Date:  2014-04       Impact factor: 6.883
  10 in total
  2 in total

1.  Brain abscess associated with Mycoplasma faucium - The initial presentation of pulmonary arteriovenous malformation.

Authors:  Ryan Rothman; Vikram Saini; Zaw Min; Nitin Bhanot
Journal:  IDCases       Date:  2022-07-14

Review 2.  [Clinical implications of the genus Mycoplasma].

Authors:  D Gómez Rufo; E García Sánchez; J E García Sánchez; M García Moro
Journal:  Rev Esp Quimioter       Date:  2021-03-18       Impact factor: 1.553
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.